Xconomy National

Archives

by in
Entry Author Date Location
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects Arlene Weintraub 02/06/12 National
Jury Convicts Financial Advisor in Murder of Life Sciences Investor Bruce V. Bigelow 11/22/11 San Diego
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships Arlene Weintraub 11/15/11 New York
Genzyme MS Drug Significantly Reduces Relapse, Disability in Late-Stage Trial Arlene Weintraub 11/14/11 Boston
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes Arlene Weintraub 11/10/11 New York
NPS Charts Positive Results on Parathyroid Drug Arlene Weintraub 11/07/11 New York
AMAG Shares Zoom on CEO Departure and Re-Org Plans Arlene Weintraub 11/04/11 Boston
NPS Pharma’s Not-So-Excellent Wall Street Adventure Arlene Weintraub 11/03/11 New York
Pacira Wins FDA Approval of Pain Drug, Cushioning Pain of 3Q Loss Arlene Weintraub 10/31/11 New York
Xconomist of the Week: Appature’s Kabir Shahani Eyes Culture as Company Expands Curt Woodward 10/14/11 Seattle
The Essential Steve Jobs for Today’s Pharmaceutical Executive Christopher Bowe 10/06/11 New York
J&J Honors Genentech Scientist, Holds Meeting on Future of Anti-Angiogenesis Drugs Arlene Weintraub 09/15/11 New York
Shire Wins Approval for Rare-Disease Drug Developed At Boston-Based Unit Arlene Weintraub 08/25/11 Boston
Regeneron Shares Fall on FDA Delay Arlene Weintraub 08/17/11 New York
Pfizer Wins Viagra Patent Case Arlene Weintraub 08/15/11 New York
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments Arlene Weintraub 08/15/11 Boston
Xconomist of the Week: Five Questions About Life Sciences Investing for Dennis Purcell of Aisling Capital Arlene Weintraub 08/04/11 New York
Ventrus Attracts Investors With Hemorrhoid Drug and Two Other Late-Stage Drug Candidates Arlene Weintraub 08/02/11 New York
IPO Activity Returns to Pre-Recession Levels in Second Quarter Bruce V. Bigelow 07/26/11 National
Amag Makes Good on Acquisition Promise, But Wall Street Balks Arlene Weintraub 07/20/11 Boston
Pfizer buys Icagen Arlene Weintraub 07/20/11 New York
Coronado Biosciences Files Form 10 Arlene Weintraub 07/18/11 New York
Organovo’s Bio-Printing Technology Yields Unanticipated Revenue from Pharma Partners Bruce V. Bigelow 07/13/11 San Diego
Amag Rebounds from FDA Handwringing, Looks To Stock Pipeline Through Acquisitions Arlene Weintraub 07/12/11 Boston
Pfizer Explores Options for Animal Health and Nutrition Arlene Weintraub 07/07/11 New York
J&J Joins Pharmasset for Hepatitis Study Arlene Weintraub 07/06/11 New York
Regado Pulls in $11.6 Million Arlene Weintraub 07/05/11 New York
Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline Arlene Weintraub 07/01/11 New York
Bristol Churns Out Diabetes Data Arlene Weintraub 06/27/11 New York
Durect Plunges on FDA Ruling Arlene Weintraub 06/24/11 San Francisco
Page 1 of 4 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.